Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial

BACKGROUND: People with severe mental illness (SMI) are two to three times more likely to be overweight and obese than the general population and this is associated with significant morbidity and premature mortality. Although lifestyle interventions can support people with SMI to lose weight, some a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Whicher, Clare Alexandra, Price, Hermione Clare, Phiri, Peter, Rathod, Shanaya, Barnard-Kelly, Katharine, Reidy, Claire, Thorne, Kerensa, Asher, Carolyn, Peveler, Robert, McCarthy, Joanne, Holt, Richard Ian Gregory
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6868690/
https://ncbi.nlm.nih.gov/pubmed/31747930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3689-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars